share_log

富士製薬工業:持続性男性ホルモン製剤「テスチノンデポー筋注用」の製造販売承認の承継について

Fuji Pharma: Succession of manufacturing and sales approval for the sustainable male hormone preparation “Testinone Depot for Muscle Injection”

JPX ·  Jul 18, 2023 14:00

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.